News, Mitteilungen, Veröffentlichungen und Events

“AI: What it is capable of today” – Expert Article from Ramin Assadollahi for IDG / PC-WELT

05.10.2017 ‐ Künstliche Intelligenz: Wozu sie heute schon imstande ist Ein Lagebericht aus der Praxis, der zeigt, dass erfolgreiche KI-Systeme nur durch menschlichen Input funktionieren können. Wer in letzter Zeit über Künstliche Intelligenz liest, erhält schnell einen bizarren Eindruck: Heute oder spätestens morgen schon werden wir es mit autonom handelnden und denkenden Maschinen zu tun haben –…

Weiterlesen

ExB Keynote zur data2day Konferenz: “Künstliche Intelligenz als Partner des Menschen” (Video)

28.09.2017 ‐ Dr. Ramin Assadollahi’s Keynote auf der data2day (Konferenz für Big Data, Data Science und Machine Learning): "Künstliche Intelligenz als Partner des Menschen: Verständnistiefe und Nützlichkeit"

Weiterlesen

Portrait of ExB Labs at t3n

30.06.2017 ‐ t3n, a German magazine for digital business and future technologies, published a portrait of ExB: ExB Labs: Dieses deutsche Unternehmen will es mit IBMs Watson aufnehmen (“ExB Labs: This German company wants compete with IBM Watson”). The article reflects the history of ExB, founded by Dr. Ramin Assadollahi. In the portrait Ramin shares his vision…

Weiterlesen

FAZ: ExB named as ground-breaking German AI firm

01.05.2017 ‐ The leading German daily newspaper Frankfurter Allgemeine Zeitung reviewed the German AI industry in its 22 April 2017 issue, naming ExB, along with Celonis and Scopevisio as ground-breaking German firms working in this key field. The article highlights how data mining, deep learning and artificial intelligence are not only “the next big thing”, but are already…

Weiterlesen

ExB invited by ZD.B to speak about Big Data Driven Healthcare

20.04.2017 ‐ Dr. Ramin Assadollahi, CEO of ExB Labs and ExB Health, is invited to participate at the upcoming event “The Future of Healthcare”. The event is organized by ZD.B (Zentrum Digitalisierung Bayern). Dr. Assadollahi will talk about “Which problems in healthcare AI can solve – and which not“. The organizers ask: “Where do we go with digitalization and…

Weiterlesen

Ramin Assadollahi to talk on Smart Data panel of BMWi at CeBIT 2017

20.03.2017 ‐ Dr. Ramin Assadollahi, CEO and Founder ExB Group, is invited to participate as an external expert on a panel discussion about “How and what to learn from Big Data – challenges and recommendations” at CeBIT 2017. The panel takes place at “Forum des BMWi”, hall 6, booth C40 on Wednesday, March 22nd 2017 and is organized by…

Weiterlesen

Dr. Peter Neubeck speaks at BIO-Europe Conference

04.11.2016 ‐ Dr. Peter Neubeck, Chief Medical Officer at ExB, is invited to speak at BIO-Europe in Cologne. BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. Dr. Neubeck will be talking at the panel discussion”Big Pharma’s approach to digital medicine” on Monday Nov 7. The convergence of new technologies and therapies is reshaping the entire landscape of healthcare.…

Weiterlesen

ExB represents Big Data Application in Biotech for Bavaria

18.07.2016 ‐ ExB was invited to the Zukunftsrat der Bayerischen Wirtschaft, an official council of the state of Bavaria to define and shape the economic future of Bavaria. The focus was on big data applications in a digital future and ExB was selected to represent the feature application in Biotechnology. Founder and CEO Dr. Ramin Assadollahi and…

Weiterlesen

ExB at the DLD-Conference in New York (Video)

28.04.2016 ‐ The DLD NYC 16 conference, taking place May 3rd and 4th in New York, is bringing together digital natives, creators and enablers from Europe, Israel and the United States. The conference has invited ExB CEO Dr. Ramin Assadollahi to speak about Artificial Intelligence followed by David Kenny, IBM Watson General Manager, with a deep talk…

Weiterlesen

Research Hospital Charité using ExB Technology to study Fibrosis treatments

24.04.2016 ‐ Berlin-based university hospital Charité is using cutting edge ExB technologies in its fibrosis research, in order to automate the analysis of tissue sections for early recognition of pathological changes. Doctor-performed histopathological analysis of liver biopsy samples is currently the gold standard for fibrosis, but is also very time-consuming. The research team of Professor Dr. Ingolf…

Weiterlesen